National Academies Press: OpenBook
« Previous: Appendix B: Workshop Agenda
Suggested Citation:"Appendix C: Registered Attendees." National Academies of Sciences, Engineering, and Medicine. 2018. Enabling Novel Treatments for Nervous System Disorders by Improving Methods for Traversing the Blood–Brain Barrier: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/25044.
×

C

Registered Attendees

Neeraj Agarwal

National Eye Institute

Diaa Ahmed

Helway University

Mark Allegretta

National Multiple Sclerosis Society

Susan Amara

National Institute of Mental Health

Forest Andrews

Eli Lilly and Company

Shelli Avenevoli

National Institute of Mental Health

Frank Avenilla

National Institute of Mental Health

David Banach

AbbVie, Inc.

Abdulai Barrie

Department of Chemical and Biological Sciences, Montgomery College, Germantown, Maryland

Isle Bastille

Harvard Medical School

William Beckett

William Beckett & Associates

Virginia Berry

Amgen

Julia Berzhanskaya

National Institutes of Health

Ruben Boado

ArmaGen

Karen Boisvert

AbbVie Inc.

Lizbet Boroughs

Association of American Universities

Suggested Citation:"Appendix C: Registered Attendees." National Academies of Sciences, Engineering, and Medicine. 2018. Enabling Novel Treatments for Nervous System Disorders by Improving Methods for Traversing the Blood–Brain Barrier: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/25044.
×

Francesca Bosetti

National Institute of Neurological Disorders and Stroke

Katja Brose

Chan Zuckerberg Initiative

Michael T. Brown

GE Global Research

Gregory Busse

Takeda Pharmaceuticals

Grant Campany

XPRIZE Foundation

Rosa Canet-Aviles

Foundation for the National Institutes of Health

Mark Carol

Sonacare Medical

Randall Carter

GE Global Research

Martin Case

Janssen Research & Development, LLC

Balu Chakravarthy

National Research Council of Canada

Ying Chan

AbbVie Inc.

Ellen Chi

Janssen Research & Development, LLC

Sylvia Chin-Caplan

Law Office of Sylvia Chin-Caplan

E. Antonio Chiocca

Harvard Medical School

Choi-Fong Cho

Brigham and Women’s Hospital, Harvard Medical School

Jennifer Cosenza

Feinstein Kean Healthcare

Johnny Croy

Eli Lilly and Company

Kangwen Deng

AbbVie Inc.

Dario Doller

Sage Therapeutics

Xavier du Maine

Harvard Medical School

Lee Dudka

Dudka & Associates

Martin A. Duenas

Leidos

Suzanne Edavettal

Janssen Research & Development, LLC

Suggested Citation:"Appendix C: Registered Attendees." National Academies of Sciences, Engineering, and Medicine. 2018. Enabling Novel Treatments for Nervous System Disorders by Improving Methods for Traversing the Blood–Brain Barrier: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/25044.
×

Emmeline Edwards

National Center for Complementary and Integrative Health

Adam Fleisher

Eli Lilly and Company

Thomas Forbes

Children’s National Health System

Peter Frinking

Bracco

Allyson Gage

Cohen Veterans Bioscience

Lei Gao

AbbVie Inc.

Hugo Geerts

In Silico Biosciences

Reza Ghodssi

University of Maryland

Alexandra Golby

Harvard Medical School, Brigham and Women’s Hospital, Department of Neurosurgery

Marjorie Gondre-Lewis

Howard University College of Medicine

Viviana Gradinaru

California Institute of Technology

Robert Greely

Biogen

Shenita-Ann Grymes

BrittNelle Health Services Group, LLC

Chenghua Gu

Harvard Medical School

Sean Han

Amgen

Joseph Hanig

Food and Drug Administration

Richard Hatzfeld

Feinstein Kean Healthcare, an Ogilvy Company

Ramona Hicks

One Mind

Stuart Hoffman

Office of Research and Development, Department of Veterans Affairs

Douglas Hunt

ArmaGen

Steven Hyman

Stanley Center for Psychiatric Research

Michael Irizarry

Eli Lilly and Company

Suggested Citation:"Appendix C: Registered Attendees." National Academies of Sciences, Engineering, and Medicine. 2018. Enabling Novel Treatments for Nervous System Disorders by Improving Methods for Traversing the Blood–Brain Barrier: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/25044.
×

Tom Jacobs

University of Texas

Brett Janosky

Amgen

Dominique Jennings

Celgene

Sophia Jeon

National Institute of Neurological Disorders and Stroke

Alexander Kabanov

Center for Nanotechnology in Drug Delivery, UNC Eshelman School of Pharmacy

Claire Kaplan

University of Maryland College Park

Kristin Kemmerich

National Research Council of Canada

Alireza Khaligh

University of Maryland

Sooja Kim

American Institute for Cancer Research

James Koenig

National Institute of Neurological Disorders and Stroke

Vinod Kulkarni

National Institute of Neurological Disorders and Stroke

Story Landis

National Institute of Neurological Disorders and Stroke (Emeritus)

Gerhard Leinenga

The University of Queensland

Na Li

Amgen

Sarah H. Lisanby

National Institute of Mental Health

Roger Little

National Institute on Drug Abuse

Linda Loyd

Ippfast Inc.

Lucy Lu

Merck

Yifeng Lu

AbbVie Inc.

Linda MacArthur

Center for Scientific Review, National Institutes of Health

Mary MacDonald

Engility

Suggested Citation:"Appendix C: Registered Attendees." National Academies of Sciences, Engineering, and Medicine. 2018. Enabling Novel Treatments for Nervous System Disorders by Improving Methods for Traversing the Blood–Brain Barrier: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/25044.
×

Husseini Manji

Janssen Research & Development, LLC

Timothy Mason

Law Office of Sylvia Chin-Caplan, LLC

Bill McCarty

Amgen

Michael McCaughan

Prevision Policy

David McMullen

Douglas Meinecke

National Institute of Mental Health

David Michelson

Merck

Laura Mitic

University of California, San Francisco Memory and Aging Center

Roscoe M. Moore, Jr.

PH RockWood LLC

Radha Murthy

Nimhans

Dylan Neel

Harvard University

Jorge L. Nina Espinosa

University of Puerto Rico

Bob Nocco

Chevron Corporation

Vicente Nunez

Harvard University

Colin O’Carroll

Ardmore Biotech Consulting

Sarah O’Connor

Amgen

Hie Page

Iason Papademetriou

Boston University

William Pardridge

University of California, Los Angeles

Taeeun Park

Harvard University

Cinthia Pastuskovas

Amgen

Mitesh Patel

Amgen

Nikunj Patel

Food and Drug Administration

Vikram Patel

Food and Drug Administration

Suggested Citation:"Appendix C: Registered Attendees." National Academies of Sciences, Engineering, and Medicine. 2018. Enabling Novel Treatments for Nervous System Disorders by Improving Methods for Traversing the Blood–Brain Barrier: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/25044.
×

Michele Pearson

National Institute of Mental Health

Nathalia Peixoto

George Mason University

Creighton Phelps

Retired, National Institute on Aging

Roger Phillips

Private consulting practice

Elizabeth Pimentel

Maryland University of Integrative Health

Andrea Pirzkall

Beigene

David Polidori

Janssen Research & Development, LLC

William Potter

National Institute of Mental Health

Darwin Prockop

Texas A&M University

Ipolia Ramadan

National Institutes of Health

Deepa Rao

Food and Drug Administration

Carolina Remos

Northwell Health

Carl Rhodes

Alexander and Associates

Max Robinowitz

Retired, Food and Drug Administration

Bob Roehr

Scientific American

Madelaine Romero

Hector Rosas-Hernandez

National Center for Toxicological Research

Susan Rosenbaum

Lauren Sciences LLC

Erik Runko

National Science Foundation

Lynn Rutkowski

Ossianix, Inc.

Ramkrishna Sadhukhan

AbbVie Inc.

Shilpa Sambashivan

Amgen

Ahmed Samir

Charite Berlin

Suggested Citation:"Appendix C: Registered Attendees." National Academies of Sciences, Engineering, and Medicine. 2018. Enabling Novel Treatments for Nervous System Disorders by Improving Methods for Traversing the Blood–Brain Barrier: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/25044.
×

Eric Schaeffer

Janssen Research & Development, LLC

Eugenia Schenecker

The George Washington University

Oliver Schmidt

Eli Lilly and Company

Ralf Seip

Sonacare Medical

Masha Sergeeva

DMPK4BIOTECH

Lisa Shafer

Teva Pharmaceuticals

Dhavalkumar Shah

University of New York at Buffalo, Department of Pharmaceutical Sciences

Lily Silayeva

Defense Threat Reduction Agency

Len Singer

Smarterage LLC

Sanjaya Singh

Janssen Pharmaceutical Companies of Johnson & Johnson

Patroula Smpokou

Department of Health and Human Services

Krystyna Solarana

Food and Drug Administration

Andrew Sostek

Katanya

Barry Springer

Janssen Research & Development, LLC

Stinivasa Srinivasa

National Institute of Mental Health and Neuro-Sciences, Bangalore, India

Danica Stanimirovic

National Research Council of Canada

Pawel Stocki

Ossianix, Inc.

Bernd Stowasser

Sanofi

Jennifer Stratton

Teva Pharmaceuticals

Ron Swanson

Janssen Research & Development, LLC

Edmund Talley

National Institute of Neurological Disorders and Stroke/BRAIN Initiative

Suggested Citation:"Appendix C: Registered Attendees." National Academies of Sciences, Engineering, and Medicine. 2018. Enabling Novel Treatments for Nervous System Disorders by Improving Methods for Traversing the Blood–Brain Barrier: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/25044.
×

Amir Tamiz

National Institute of Neurological Disorders and Stroke

Ben Tang

Amgen

Hiroaki Tani

Eli Lilly and Company

Lorin Thompson

Fulcrum Therapeutics

Robert Thorne

University of Wisconsin–Madison

Jason Tien

Teva Pharmaceuticals

Kelsie Timbie

Focused Ultrasound Foundation

Wendy Toler

Consultant, Medical Affairs/Clinical Development

Alan Trachtenberg

Food and Drug Administration

Kathleen Tusaie

William Beckett & Associates

Rebecca Voelker

Journal of the American Medical Association

Meredith Wadman

Science magazine

Owen Wallace

Fulcrum Therapeutics

Frank Walsh

Ossianix, Inc.

Kuan Wang

Taipei Medical University

Lily Wang

Maimonides Cancer Center

Alex Watters

Wyss Institute

Andrew Welchman

The Wellcome Trust

Cole Werble

Prevision Policy, LLC

Matthew Whittaker

Food and Drug Administration

Krzysztof Wicher

Ossianix, Inc.

Dionna Williams

Johns Hopkins University

Dan Wolak

Amgen

Winifred Wu

Strategic Regulatory Partners, LLC

Suggested Citation:"Appendix C: Registered Attendees." National Academies of Sciences, Engineering, and Medicine. 2018. Enabling Novel Treatments for Nervous System Disorders by Improving Methods for Traversing the Blood–Brain Barrier: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/25044.
×

Shuyan Yi

Amgen

Nathan Yoganathan

KalGene Pharmaceuticals Inc.

Claudia Zamora

Zamora Consulting Group

Mark Zervas

Amgen

Berislav Zlokovic

University of Southern California

Suggested Citation:"Appendix C: Registered Attendees." National Academies of Sciences, Engineering, and Medicine. 2018. Enabling Novel Treatments for Nervous System Disorders by Improving Methods for Traversing the Blood–Brain Barrier: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/25044.
×

This page intentionally left blank.

Suggested Citation:"Appendix C: Registered Attendees." National Academies of Sciences, Engineering, and Medicine. 2018. Enabling Novel Treatments for Nervous System Disorders by Improving Methods for Traversing the Blood–Brain Barrier: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/25044.
×
Page 51
Suggested Citation:"Appendix C: Registered Attendees." National Academies of Sciences, Engineering, and Medicine. 2018. Enabling Novel Treatments for Nervous System Disorders by Improving Methods for Traversing the Blood–Brain Barrier: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/25044.
×
Page 52
Suggested Citation:"Appendix C: Registered Attendees." National Academies of Sciences, Engineering, and Medicine. 2018. Enabling Novel Treatments for Nervous System Disorders by Improving Methods for Traversing the Blood–Brain Barrier: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/25044.
×
Page 53
Suggested Citation:"Appendix C: Registered Attendees." National Academies of Sciences, Engineering, and Medicine. 2018. Enabling Novel Treatments for Nervous System Disorders by Improving Methods for Traversing the Blood–Brain Barrier: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/25044.
×
Page 54
Suggested Citation:"Appendix C: Registered Attendees." National Academies of Sciences, Engineering, and Medicine. 2018. Enabling Novel Treatments for Nervous System Disorders by Improving Methods for Traversing the Blood–Brain Barrier: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/25044.
×
Page 55
Suggested Citation:"Appendix C: Registered Attendees." National Academies of Sciences, Engineering, and Medicine. 2018. Enabling Novel Treatments for Nervous System Disorders by Improving Methods for Traversing the Blood–Brain Barrier: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/25044.
×
Page 56
Suggested Citation:"Appendix C: Registered Attendees." National Academies of Sciences, Engineering, and Medicine. 2018. Enabling Novel Treatments for Nervous System Disorders by Improving Methods for Traversing the Blood–Brain Barrier: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/25044.
×
Page 57
Suggested Citation:"Appendix C: Registered Attendees." National Academies of Sciences, Engineering, and Medicine. 2018. Enabling Novel Treatments for Nervous System Disorders by Improving Methods for Traversing the Blood–Brain Barrier: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/25044.
×
Page 58
Suggested Citation:"Appendix C: Registered Attendees." National Academies of Sciences, Engineering, and Medicine. 2018. Enabling Novel Treatments for Nervous System Disorders by Improving Methods for Traversing the Blood–Brain Barrier: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/25044.
×
Page 59
Suggested Citation:"Appendix C: Registered Attendees." National Academies of Sciences, Engineering, and Medicine. 2018. Enabling Novel Treatments for Nervous System Disorders by Improving Methods for Traversing the Blood–Brain Barrier: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/25044.
×
Page 60
Enabling Novel Treatments for Nervous System Disorders by Improving Methods for Traversing the Blood–Brain Barrier: Proceedings of a Workshop Get This Book
×
Buy Paperback | $55.00 Buy Ebook | $44.99
MyNAP members save 10% online.
Login or Register to save!
Download Free PDF

Despite substantial advances in developing treatments for the serious illnesses that affect people worldwide, there remains a tremendous unmet need in the treatment of complex neurologic diseases, including neuropsychiatric and neurodegenerative disorders. Chief among the challenges that have hindered the development of therapeutics for central nervous system (CNS) disorders is the blood–brain barrier (BBB). The Forum on Neuroscience and Nervous System Disorders of the National Academies of Sciences, Engineering, and Medicine convened a workshop to explore the challenges associated with the BBB that have thus far stymied development of CNS drugs, examine new technologies that could address these challenges, and highlight potential opportunities for moving the field forward. This publication summarizes the presentations and discussions from the workshop.

  1. ×

    Welcome to OpenBook!

    You're looking at OpenBook, NAP.edu's online reading room since 1999. Based on feedback from you, our users, we've made some improvements that make it easier than ever to read thousands of publications on our website.

    Do you want to take a quick tour of the OpenBook's features?

    No Thanks Take a Tour »
  2. ×

    Show this book's table of contents, where you can jump to any chapter by name.

    « Back Next »
  3. ×

    ...or use these buttons to go back to the previous chapter or skip to the next one.

    « Back Next »
  4. ×

    Jump up to the previous page or down to the next one. Also, you can type in a page number and press Enter to go directly to that page in the book.

    « Back Next »
  5. ×

    Switch between the Original Pages, where you can read the report as it appeared in print, and Text Pages for the web version, where you can highlight and search the text.

    « Back Next »
  6. ×

    To search the entire text of this book, type in your search term here and press Enter.

    « Back Next »
  7. ×

    Share a link to this book page on your preferred social network or via email.

    « Back Next »
  8. ×

    View our suggested citation for this chapter.

    « Back Next »
  9. ×

    Ready to take your reading offline? Click here to buy this book in print or download it as a free PDF, if available.

    « Back Next »
Stay Connected!